Debra B Alexander

Title: Debra B. Alexander: Innovator in Cancer Immunoassays

Introduction

Debra B. Alexander is a prominent inventor based in Gurnee, IL (US). She has made significant contributions to the field of cancer immunoassays, particularly in the development of methods for detecting prostate-specific antigen (PSA). With a total of 2 patents to her name, her work has the potential to impact cancer diagnostics significantly.

Latest Patents

Debra's latest patents focus on innovative immunoassay methods for prostate-specific antigen (PSA). These inventions present a new approach to cancer immunoassays, introducing a complex that resembles the interaction between PSA and α-antichymotrypsin (ACT). This complex can serve as a calibrator or control in immunoassays for PSA. Additionally, her patents include methods for fractionating polyclonal antibodies to PSA, distinguishing between those that bind to masked epitopes and those that do not.

Career Highlights

Debra B. Alexander is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on advancing cancer diagnostics through innovative research and development.

Collaborations

Throughout her career, Debra has collaborated with notable colleagues, including Barry Lee Dowell and Carol A. King. These collaborations have contributed to her success and the advancement of her research in immunoassays.

Conclusion

Debra B. Alexander's contributions to the field of cancer immunoassays exemplify her dedication to improving diagnostic methods for prostate cancer. Her innovative patents and collaborations highlight her role as a key figure in this important area of medical research.